Attached files
file | filename |
---|---|
10-K - Jiangbo Pharmaceuticals, Inc. | v197623_10k.htm |
EX-31.2 - Jiangbo Pharmaceuticals, Inc. | v197623_ex31-2.htm |
EX-32.2 - Jiangbo Pharmaceuticals, Inc. | v197623_ex32-2.htm |
EX-31.1 - Jiangbo Pharmaceuticals, Inc. | v197623_ex31-1.htm |
EX-99.8 - Jiangbo Pharmaceuticals, Inc. | v197623_ex99-8.htm |
EXHIBIT
32.1
CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT
TO 18 USC § 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY
ACT OF 2002
In
connection with the annual report of Jiangbo Pharmaceuticals, Inc. (“the
Company”) on Form 10-K for the period ended June 30, 2010 as filed with the
Securities and Exchange Commission on the date hereof (“the Report”), I, Jin
Linxian, Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my
knowledge:
|
(a)
|
The
annual report on Form 10-K for the year ended June 30, 2010 of the Company
fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934;
and
|
|
(b)
|
Information contained in the Form
10-K fairly presents, in all material respects, the financial condition
and results of operations of the
Company.
|
Dated:
September 28, 2010
/s/ Jin Linxian
|
|
Jin
Linxian
|
|
Chief
Executive Officer
|